Morrice L M, McLean M W, Long W F, Williamson F B
Eur J Biochem. 1983 Dec 1;137(1-2):149-54. doi: 10.1111/j.1432-1033.1983.tb07808.x.
Beta-Agarase I and II were characterised by their action on agar-type polysaccharides and oligosaccharides. Beta-Agarase I, an endo-enzyme, was specific for regions containing a minimum of one unsubstituted neoagarobiose unit [3,6-anhydro-alpha-L-galactopyranosyl-(1 leads to 3)-D-galactose], hydrolysing at the reducing side of this moiety. Yaphe demonstrated that agar was degraded by this enzyme to neoagaro-oligosaccharides limited by the disaccharide but with a predominance of the tetramer [Yaphe, W. (1957) Can. J. Microbiol. 3, 987-993]. Beta-Agarase I slowly degraded neoagarohexaose but not the homologous tetrasaccharide. [1-3H]Neoagarohexaitol was cleaved to neoagarotetraose and [1-3H]neoagarobiitol. The highly substituted agar, porphyran was degraded to methylated, sulphated and unsubstituted neoagaro-oligosaccharides which were invariably terminated at the reducing end by unsubstituted neoagarobiose. The novel enzyme, beta-agarase II, was shown to be an endo-enzyme. Preliminary evidence indicated this enzyme was specific for sequences containing neoagarobiose and/or 6(1)-O-methyl-neoagarobiose. It degraded agar to neoagaro-oligosaccharides of which the disaccharide was limiting and predominant. Beta-Agarase II rapidly degraded isolated neogarotetraose and neoagarohexaose to the disaccharide. With [1-3H]neoagarohexaitol, exo-action was observed, the alditol being cleaved to neoagarobiose and [1-3H]neoagarotetraitol. Neoagarotetraitol was hydrolysed at 4% of the rate observed for the hexaitol. Porphyran was degraded to oligosaccharides, the neutral fraction comprising 24% of the starting carbohydrate. This fraction was almost exclusively disaccharides (22.4%) containing neoagarobiose (7.4%) and 6(1)-O-methyl-neoagarobiose (15%). Beta-Agarase II is probably the 'beta-neoagarotetraose hydrolase' reported by Groleau and Yaphe as an exoenzyme against neoagaro-oligosaccharides [Groleau, D. and Yaphe, W. (1977) Can. J. Microbiol. 23, 672-679].
β-琼脂酶I和II通过它们对琼脂型多糖和寡糖的作用来表征。β-琼脂酶I是一种内切酶,对含有至少一个未取代新琼脂二糖单元[3,6-脱水-α-L-吡喃半乳糖基-(1→3)-D-半乳糖]的区域具有特异性,在该部分的还原端进行水解。亚菲证明,这种酶将琼脂降解为受二糖限制但以四糖为主的新琼脂寡糖[亚菲,W.(1957年)。《加拿大微生物学杂志》3,987 - 993]。β-琼脂酶I缓慢降解新琼脂六糖,但不降解同源四糖。[1 - 3H]新琼脂己糖醇被裂解为新琼脂四糖和[1 - 3H]新琼脂二糖醇。高度取代的琼脂,紫菜聚糖被降解为甲基化、硫酸化和未取代的新琼脂寡糖,这些寡糖在还原端总是由未取代的新琼脂二糖终止。新型酶β-琼脂酶II被证明是一种内切酶。初步证据表明该酶对含有新琼脂二糖和/或6(1)-O-甲基新琼脂二糖的序列具有特异性。它将琼脂降解为新琼脂寡糖,其中二糖是限制性的且占主导。β-琼脂酶II迅速将分离的新琼脂四糖和新琼脂六糖降解为二糖。对于[1 - 3H]新琼脂己糖醇,观察到外切作用,糖醇被裂解为新琼脂二糖和[1 - 3H]新琼脂四糖醇。新琼脂四糖醇的水解速率为己糖醇观察速率的4%。紫菜聚糖被降解为寡糖,中性部分占起始碳水化合物的24%。该部分几乎完全是二糖(22.4%),含有新琼脂二糖(7.4%)和6(1)-O-甲基新琼脂二糖(15%)。β-琼脂酶II可能是格罗勒奥和亚菲报道的作为针对新琼脂寡糖的外切酶的“β-新琼脂四糖水解酶”[格罗勒奥,D.和亚菲,W.(1977年)。《加拿大微生物学杂志》23,672 - 679]。